
Cory Kasimov
Stock Analyst at Evercore ISI
(4.89)
# 304
Out of 5,189 analysts
1033
Total ratings
56.3%
Success rate
17%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $120 | $60.41 | +98.64% | 85 | Nov 13, 2026 | |
| ETRA Electra Therapeutics | Reiterated: Buy | $36 | $8.11 | +343.90% | 2 | Nov 13, 2026 | |
| MRNA Moderna | Reiterated: Hold | $80 | $195.00 | -58.97% | 51 | Nov 13, 2026 | |
| COAG Hemab Therapeutics Holdings | Reiterated: Buy | $50 → $65 | $39.29 | +65.44% | 2 | Nov 11, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $72 | $48.13 | +49.59% | 4 | Nov 11, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $15.69 | +154.94% | 9 | Nov 10, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $22 → $25 | $8.39 | +197.97% | 7 | Nov 10, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $80 | $37.04 | +115.98% | 8 | Nov 10, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $100 | $50.78 | +96.93% | 13 | Nov 5, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $55 | $39.91 | +37.83% | 11 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 → $340 | $161.20 | +110.92% | 8 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $9.95 | +241.71% | 13 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $76.03 | +70.99% | 21 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $20.90 | +115.31% | 9 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $80.96 | +60.57% | 33 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.92 | +215.86% | 2 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $325 | $143.82 | +126.12% | 8 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 → $215 | $150.57 | +42.79% | 17 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.36 | +239.67% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $535 | $515.02 | +3.88% | 61 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $875 → $825 | $920.69 | -10.39% | 77 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $1.59 | +843.40% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $23.85 | +130.61% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 → $128 | $16.48 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $84 | $10.71 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $44.94 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $219 → $221 | $249.59 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $17.11 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $11 | $1.59 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $20 | $0.6277 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 → $16 | $1.64 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 → $227 | $435.64 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $98 → $86 | $114.63 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $15.25 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.18 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $74 | $166.43 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $7.05 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $78.62 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.40 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.82 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.85 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $100 | $1,347.11 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $276.72 | $11.81 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.106 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.66 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $7.47 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $68 | $26.58 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $310.53 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $7.22 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.000001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $40.09 | n/a | 1 | Jun 4, 2013 |
BioMarin Pharmaceutical
Nov 13, 2026
Reiterated: Buy
Price Target: $120
Current: $60.41
Upside: +98.64%
Electra Therapeutics
Nov 13, 2026
Reiterated: Buy
Price Target: $36
Current: $8.11
Upside: +343.90%
Moderna
Nov 13, 2026
Reiterated: Hold
Price Target: $80
Current: $195.00
Upside: -58.97%
Hemab Therapeutics Holdings
Nov 11, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $39.29
Upside: +65.44%
Scholar Rock Holding
Nov 11, 2026
Reiterated: Buy
Price Target: $72
Current: $48.13
Upside: +49.59%
Immunome
Nov 10, 2026
Reiterated: Buy
Price Target: $40
Current: $15.69
Upside: +154.94%
Vir Biotechnology
Nov 10, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $8.39
Upside: +197.97%
Xenon Pharmaceuticals
Nov 10, 2026
Reiterated: Buy
Price Target: $80
Current: $37.04
Upside: +115.98%
Cytokinetics
Nov 5, 2026
Reiterated: Buy
Price Target: $100
Current: $50.78
Upside: +96.93%
Edgewise Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $55
Current: $39.91
Upside: +37.83%
Nov 5, 2026
Reiterated: Buy
Price Target: $320 → $340
Current: $161.20
Upside: +110.92%
Nov 5, 2026
Reiterated: Buy
Price Target: $34
Current: $9.95
Upside: +241.71%
Oct 30, 2026
Reiterated: Buy
Price Target: $130
Current: $76.03
Upside: +70.99%
Oct 28, 2026
Reiterated: Buy
Price Target: $45
Current: $20.90
Upside: +115.31%
Oct 13, 2026
Reiterated: Buy
Price Target: $130
Current: $80.96
Upside: +60.57%
Sep 15, 2026
Reiterated: Buy
Price Target: $25
Current: $7.92
Upside: +215.86%
Aug 31, 2026
Reiterated: Buy
Price Target: $325
Current: $143.82
Upside: +126.12%
Aug 17, 2026
Reiterated: Buy
Price Target: $210 → $215
Current: $150.57
Upside: +42.79%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $7.36
Upside: +239.67%
Aug 4, 2026
Reiterated: Buy
Price Target: $535
Current: $515.02
Upside: +3.88%
May 18, 2026
Reiterated: Buy
Price Target: $875 → $825
Current: $920.69
Upside: -10.39%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $1.59
Upside: +843.40%
Mar 17, 2026
Reiterated: Buy
Price Target: $55
Current: $23.85
Upside: +130.61%
Jul 29, 2022
Reiterated: Buy
Price Target: $126 → $128
Current: $16.48
Upside: n/a
Jul 28, 2022
Reiterated: Hold
Price Target: $91 → $84
Current: $10.71
Upside: n/a
Jul 27, 2022
Reiterated: Hold
Price Target: $30 → $33
Current: $44.94
Upside: n/a
Jul 20, 2022
Reiterated: Hold
Price Target: $219 → $221
Current: $249.59
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $17.11
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $14 → $11
Current: $1.59
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $24 → $20
Current: $0.6277
Upside: n/a
May 4, 2022
Reiterated: Sell
Price Target: $19 → $16
Current: $1.64
Upside: n/a
Apr 28, 2022
Reiterated: Hold
Price Target: $235 → $227
Current: $435.64
Upside: n/a
Feb 9, 2022
Reiterated: Hold
Price Target: $98 → $86
Current: $114.63
Upside: n/a
Nov 19, 2021
Reiterated: Buy
Price Target: $61
Current: $15.25
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $11.18
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $74
Current: $166.43
Upside: n/a
Feb 25, 2021
Reiterated: Sell
Price Target: n/a
Current: $7.05
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $78.62
Upside: n/a
Nov 13, 2019
Reiterated: Buy
Price Target: n/a
Current: $35.40
Upside: n/a
Jun 26, 2018
Reiterated: Sell
Price Target: n/a
Current: $3.82
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $3.85
Upside: n/a
Apr 11, 2017
Reiterated: Buy
Price Target: $384 → $100
Current: $1,347.11
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $276.72
Current: $11.81
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.106
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $1.66
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $7.47
Upside: n/a
Jun 8, 2015
Reiterated: Hold
Price Target: $65 → $68
Current: $26.58
Upside: n/a
Jan 13, 2015
Reiterated: Hold
Price Target: n/a
Current: $310.53
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $7.22
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.000001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $40.09
Upside: n/a